Cognitive impairment following hormone therapy: current opinion of research in breast and prostate cancer patients. [electronic resource]
Producer: 20180105Description: 38-45 p. digitalISSN:- 1751-4266
- Androgen Antagonists -- adverse effects
- Breast Neoplasms -- drug therapy
- Clinical Trials as Topic
- Cognitive Dysfunction -- chemically induced
- Estrogen Antagonists -- adverse effects
- Female
- Hormone Antagonists -- administration & dosage
- Humans
- Male
- Prostatic Neoplasms -- drug therapy
- Selective Estrogen Receptor Modulators -- adverse effects
No physical items for this record
Publication Type: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.